UNCY
Unicycive Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.72
+3.48%Forward multiples
Based on analyst estimates
- P/E forward
- 8.38x
- P/E 2026E
- —
- P/E 2027E
- 2.61x
- P/E 2028E
- 0.42x
- P/S forward
- 1.35x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.94x
- Price / sales
- —
- Price / cash flow
- -3.72x
Enterprise value
- Enterprise value
- $42.7M
- EV / sales
- —
- EV / EBITDA
- -1.24x
- EV / EBIT
- -1.29x
- Market cap
- $103.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026